54 related articles for article (PubMed ID: 27515395)
21. Age-Dependent Increase in Incidence of Staphylococcus aureus Bacteremia, Denmark, 2008-2015.
Thorlacius-Ussing L; Sandholdt H; Larsen AR; Petersen A; Benfield T
Emerg Infect Dis; 2019 May; 25(5):875-82. PubMed ID: 31002300
[TBL] [Abstract][Full Text] [Related]
22. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
[TBL] [Abstract][Full Text] [Related]
23. Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia.
Turner NA; Moehring R; Sarubbi C; Wrenn RH; Drew RH; Cunningham CK; Fowler VG; Anderson DJ
Open Forum Infect Dis; 2018 Mar; 5(3):ofy042. PubMed ID: 29594180
[TBL] [Abstract][Full Text] [Related]
24. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
25. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
[TBL] [Abstract][Full Text] [Related]
26. Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
López-Cortés LE; Velasco C; Retamar P; del Toro MD; Gálvez-Acebal J; de Cueto M; García-Luque I; Caballero FJ; Pascual A; Rodríguez-Baño J
J Antimicrob Chemother; 2015 Sep; 70(9):2652-60. PubMed ID: 26023210
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
28. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
Rindone JP; Mellen CK
Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
[TBL] [Abstract][Full Text] [Related]
31. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Vardakas KZ; Apiranthiti KN; Falagas ME
Int J Antimicrob Agents; 2014 Dec; 44(6):486-92. PubMed ID: 25311850
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
33. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges.
Kern WV
Curr Opin Infect Dis; 2010 Aug; 23(4):346-58. PubMed ID: 20592532
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
